Renaissance Technologies
MRNS

Renaissance Technologies’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Renaissance Technologies’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-501,931
Closed -$883K – 4024
2024
Q3 		$883K Sell
501,931
-119,694
-19% -$167K ﹤0.01% 2520
2024
Q2 		$727K Buy
+621,625
New +$1.56M ﹤0.01% 2500
2023
Q3 		– Sell
-62,600
Closed -$680K – 4230
2023
Q2 		$680K Sell
62,600
-68,700
-52% -$588K ﹤0.01% 2709
2023
Q1 		$906K Sell
131,300
-31,400
-19% -$197K ﹤0.01% 2545
2022
Q4 		$648K Sell
162,700
-30,625
-16% -$151K ﹤0.01% 2793
2022
Q3 		$1.29M Buy
193,325
+36,425
+23% +$224K ﹤0.01% 2342
2022
Q2 		$759K Buy
156,900
+123,000
+363% +$748K ﹤0.01% 2892
2022
Q1 		$317K Buy
+33,900
New +$337K ﹤0.01% 3451
2020
Q3 		– Sell
-10,950
Closed -$111K – 3779
2020
Q2 		$111K Buy
+10,950
New +$101K ﹤0.01% 3258
2020
Q1 		– Sell
-3,650
Closed -$32K – 3895
2019
Q4 		$32K Buy
+3,650
New +$20.5K ﹤0.01% 3428
2018
Q2 		– Sell
-105,100
Closed -$1.61M – 3600
2018
Q1 		$1.61M Sell
105,100
-47,819
-31% -$1.14M ﹤0.01% 2448
2017
Q4 		$4.99M Buy
152,919
+76,975
+101% +$2.07M 0.01% 1805
2017
Q3 		$1.78M Buy
+75,944
New +$851K ﹤0.01% 2340

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies's MRNS Position: Q4 2024 in Review

Renaissance Technologies sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 501,931 shares — an estimated $883K sold.

Renaissance Technologies first reported a position in MRNS in Q3 2017 and held it in 13 quarters. The position peaked at $4.99M in Q4 2017. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Renaissance Technologies reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 501,931 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $883K.
  • Renaissance Technologies first reported a position in Marinus Pharmaceuticals, Inc in Q3 2017 and held it in 13 quarters.
  • Renaissance Technologies's Marinus Pharmaceuticals, Inc position peaked at $4.99M in Q4 2017.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.